[177Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastases. - Belge Bilgin G; Bilgin C; Burkett BJ; Thorpe MP; Packard AT; Fidanli F; Childs DS; Muniz M; Orme JJ; Quevedo JF; Kizilbash SH; Kwon ED; et al. (European journal of nuclear medicine and molecular imaging, 2026)